RAPT Therapeutics, Inc. (RAPT) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts RAPT Hot Sheet
Join SI Premium – FREE
RAPT Therapeutics, Inc. (NASDAQ: RAPT) reported Q2 EPS of ($0.71), $0.01 better than the analyst estimate of ($0.72).
For earnings history and earnings-related data on RAPT Therapeutics, Inc. (RAPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- GameStop CEO Ryan Cohen buys 1 million shares of GME stock
- Barrington Research Upgrades Copart (CPRT) to Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
